González-Hedström Daniel, Amor Sara, de la Fuente-Fernández María, Tejera-Muñoz Antonio, Priego Teresa, Martín Ana Isabel, López-Calderón Asunción, Inarejos-García Antonio Manuel, García-Villalón Ángel Luís, Granado Miriam
Departamento de Fisiología, Facultad de Medicina, Universidad Autónoma de Madrid, 28029 Madrid, Spain.
Pharmactive Biotech Products S.L. Parque Científico de Madrid. Avenida del Doctor Severo Ochoa, 37 Local 4J, Alcobendas, 28108 Madrid, Spain.
Antioxidants (Basel). 2020 Jun 3;9(6):483. doi: 10.3390/antiox9060483.
Aging is one of the major risk factors for suffering cardiovascular and metabolic diseases. Due to the increase in life expectancy, there is a strong interest in the search for anti-aging strategies to treat and prevent these aging-induced disorders. Both omega 3 polyunsaturated fatty acids (ω-3 PUFA) and extra virgin olive oil (EVOO) exert numerous metabolic and cardiovascular benefits in the elderly. In addition, EVOO constitutes an interesting ingredient to stabilize ω-3 PUFA and decrease their oxidation process due to its high content in antioxidant compounds. ω-3 PUFA are commonly obtained from fish. However, more ecological and sustainable sources, such as algae oil (AO) can also be used. In this study, we aimed to study the possible beneficial effect of an oil mixture composed by EVOO (75%) and AO (25%) rich in ω-3 PUFA (35% docosahexaenoic acid (DHA) and 20% eicosapentaenoic acid (EPA)) on the cardiometabolic alterations associated with aging. For this purpose; young (three months old) and old (24 months old) male Wistar rats were treated with vehicle or with the oil mixture (2.5 mL/kg) for 21 days. Treatment with the oil mixture prevented the aging-induced increase in the serum levels of saturated fatty acids (SFA) and the aging-induced decrease in the serum concentrations of mono-unsaturated fatty acids (MUFA). Old treated rats showed increased serum concentrations of EPA and DHA and decreased HOMA-IR index and circulating levels of total cholesterol, insulin and IL-6. Treatment with the oil mixture increased the mRNA levels of antioxidant and insulin sensitivity-related enzymes, as well as reduced the gene expression of pro-inflammatory markers in the liver and in cardiac and aortic tissues. In addition, the treatment also prevented the aging-induced endothelial dysfunction and vascular insulin resistance through activation of the PI3K/Akt pathway. Moreover, aortic rings from old rats treated with the oil mixture showed a decreased response to the vasoconstrictor AngII. In conclusion, treatment with a mixture of EVOO and AO improves the lipid profile, insulin sensitivity and vascular function in aged rats and decreases aging-induced inflammation and oxidative stress in the liver, and in the cardiovascular system. Thus, it could be an interesting strategy to deal with cardiometabolic alterations associated with aging.
衰老为患心血管疾病和代谢疾病的主要风险因素之一。由于预期寿命的增加,人们对寻找抗衰老策略来治疗和预防这些由衰老引发的病症有着浓厚兴趣。ω-3多不饱和脂肪酸(ω-3 PUFA)和特级初榨橄榄油(EVOO)对老年人都具有诸多代谢和心血管方面的益处。此外,由于EVOO富含抗氧化化合物,它是一种稳定ω-3 PUFA并减少其氧化过程的有趣成分。ω-3 PUFA通常从鱼类中获取。然而,也可使用更具生态性和可持续性的来源,如藻油(AO)。在本研究中,我们旨在研究由富含ω-3 PUFA(35%二十二碳六烯酸(DHA)和20%二十碳五烯酸(EPA))的EVOO(75%)和AO(25%)组成的油混合物对与衰老相关的心脏代谢改变可能产生的有益作用。为此,将年轻(三个月大)和年老(24个月大)的雄性Wistar大鼠用赋形剂或油混合物(2.5 mL/kg)处理21天。用油混合物进行处理可防止衰老诱导的饱和脂肪酸(SFA)血清水平升高以及衰老诱导的单不饱和脂肪酸(MUFA)血清浓度降低。经处理的老年大鼠血清中EPA和DHA浓度升高,HOMA-IR指数以及总胆固醇、胰岛素和IL-6的循环水平降低。用油混合物进行处理可增加抗氧化和胰岛素敏感性相关酶的mRNA水平,并降低肝脏以及心脏和主动脉组织中促炎标志物的基因表达。此外,该处理还通过激活PI3K/Akt途径防止衰老诱导的内皮功能障碍和血管胰岛素抵抗。而且,用油混合物处理的老年大鼠的主动脉环对血管收缩剂AngII的反应减弱。总之,用EVOO和AO的混合物进行处理可改善老年大鼠的血脂谱、胰岛素敏感性和血管功能,并减少衰老诱导的肝脏以及心血管系统中的炎症和氧化应激。因此,这可能是应对与衰老相关的心脏代谢改变的一种有趣策略。